Are AI Medical Scribes Legal in Australia? Privacy, Consent, and TGA Rules Explained

AI-powered clinical documentation tools are rapidly gaining traction in Australian general practice and specialist clinics, but adoption raises legitimate legal questions. Platforms like Scribing.io use ambient AI to convert physician-patient conversations into structured clinical notes — a workflow that intersects with Commonwealth privacy law, state surveillance legislation, and medical device regulation in ways that demand careful attention from every practitioner.

This guide breaks down the legal framework Australian physicians must navigate when using an AI medical scribe. Whether you operate a suburban GP clinic, a metropolitan specialist practice, or a telehealth service spanning multiple states, the rules are specific, the penalties are real, and the compliance obligations fall squarely on the treating clinician. Scribing.io was built with these requirements in mind — but understanding the law yourself is non-negotiable.

Key Takeaways

• Yes, AI medical scribes are legal in Australia, but physicians must navigate a patchwork of Commonwealth and state/territory laws covering privacy, surveillance, therapeutic goods regulation, and informed consent.

• The Privacy Act 1988 (Cth) governs how patient health information is collected, used, disclosed, and stored. Health data is classified as sensitive information, triggering elevated consent thresholds.

• Surveillance Devices Acts in each state and territory regulate audio recording of consultations — the majority require all-party consent before recording begins.

• The TGA has clarified that digital scribes are only classified as medical devices if they analyse or interpret clinical conversations (e.g., generating diagnoses or treatment recommendations). Transcription-only tools are not regulated as medical devices.

• Physicians remain personally responsible for verifying the accuracy of AI-generated notes, obtaining informed consent, and ensuring the scribe vendor has adequate data protection safeguards.

Table of Contents

• Are AI Medical Scribes Legal in Australia? The Short Answer

• Australian Privacy Law and AI Scribes — What the Privacy Act 1988 Requires

• State and Territory Surveillance Laws — Recording Consultations Legally

• TGA Regulation — When an AI Scribe Becomes a Medical Device

• AHPRA, Professional Obligations, and Clinical Responsibility

• Informed Consent Best Practices for Australian Clinicians

• Telehealth and Cross-Border Complications

• Choosing a Compliant AI Scribe Vendor

• Get Started Today

Are AI Medical Scribes Legal in Australia? The Short Answer

AI medical scribes are legal to use in Australia. No Commonwealth or state law prohibits physicians from deploying ambient AI documentation tools in clinical practice. Adoption is growing across general practice, psychiatry, cardiology, and telehealth — driven by the same documentation burden that affects clinicians globally.

However, legality is not a blanket yes/no question. Whether your specific use of an AI scribe is lawful depends on how the tool is used, what patient data it processes, and whether informed consent has been properly obtained. Australian physicians must understand three pillars of compliance:

1. Privacy law — the Privacy Act 1988 (Cth) and Australian Privacy Principles govern the collection, use, disclosure, and storage of health information.

2. Surveillance and recording law — each state and territory has separate legislation regulating when and how private conversations can be recorded.

3. Therapeutic goods regulation — the Therapeutic Goods Administration (TGA) determines whether an AI scribe crosses the line from documentation tool to regulated medical device.

Australia's regulatory approach differs meaningfully from other jurisdictions. The United States, for example, has no single federal privacy framework governing AI scribes — compliance there involves navigating HIPAA, state-by-state recording laws, and varying consent requirements. For clinicians interested in comparing frameworks, our guide to AI scribe laws in California illustrates how fragmented US regulation can become. Australia's model, centred on the Privacy Act, is more unified at the Commonwealth level, but the state-by-state surveillance laws introduce their own complexity.

Professional bodies also weigh in. The Australian Health Practitioner Regulation Agency (AHPRA) expects clinicians using AI tools to maintain the same standard of care as those using traditional documentation methods. The Australian Commission on Safety and Quality in Health Care (ACSQHC) has published guidance on AI in clinical settings, emphasising that the treating physician — not the software — bears responsibility for the accuracy of the medical record.

Australian Privacy Law and AI Scribes — What the Privacy Act 1988 Requires

The Privacy Act 1988 (Cth) is the cornerstone of Australian data protection law, and its Australian Privacy Principles (APPs) directly regulate how physicians handle patient information collected by an AI scribe. Four APPs are particularly relevant.

APP 3 — Collection of Personal Information

Health information is classified as sensitive information under the Act, which means it can only be collected with the individual's consent and only when it is reasonably necessary for the practice's functions. When an AI scribe records and transcribes a consultation, that constitutes collection. Physicians must ensure the patient has consented to this specific form of collection — a general consent to treatment is not sufficient.

APP 6 — Use and Disclosure

Once collected, health information can only be used for the primary purpose for which it was gathered (clinical documentation) or a directly related secondary purpose the patient would reasonably expect. Sharing audio files or transcripts with an AI vendor for processing falls within the primary purpose, provided the vendor is acting as a contracted service provider. However, if the vendor uses de-identified data to train its models, that secondary use requires separate disclosure and, ideally, explicit consent.

APP 8 — Cross-Border Disclosure

If the AI scribe vendor processes or stores data outside Australia, the physician must take reasonable steps to ensure the overseas recipient complies with the APPs. This is a critical point: under APP 8, the disclosing entity (the practice) remains liable for any breach by the offshore recipient. Physicians should verify where the vendor's servers are located, which sub-processors handle the data, and whether the vendor's contractual terms guarantee APP-equivalent protections.

APP 11 — Security of Personal Information

Practices must take reasonable steps to protect health information from misuse, interference, loss, unauthorised access, modification, or disclosure. This extends to the AI scribe vendor's infrastructure. Physicians should request evidence of encryption standards, access controls, and breach notification protocols before onboarding any tool.

Practice Privacy Policy Updates

Physicians are required to update their practice privacy policy to disclose: (a) that an AI scribe is used during consultations, (b) the identity of the software provider, (c) whether data is stored offshore and in which countries, and (d) what data is shared with the provider and for what purposes.

The Privacy Act Review and Upcoming Reforms

The Australian Government's ongoing Privacy Act Review proposes reforms including a statutory tort for serious invasions of privacy and a children's privacy code. Both are directly relevant to AI scribe vendors and practices treating paediatric patients. Clinicians working with younger populations — as discussed in our guide to AI scribes in paediatrics — should monitor these reforms closely.

OAIC Enforcement

The Office of the Australian Information Commissioner (OAIC) has the power to investigate complaints, conduct assessments, and issue binding determinations. Physicians are not shielded from regulatory action by pointing to a third-party vendor. The practice is the entity that collected the information, and the practice is accountable.

View Scribing.io Pricing

State and Territory Surveillance Laws — Recording Consultations Legally

This is where Australian physicians encounter the most confusion — and where the legal consequences of non-compliance are most immediate. Australia does not have a single national surveillance law. Each state and territory has its own legislation governing the recording of private conversations, and the rules vary.

*Queensland technically permits one-party consent, but clinical best practice — and APP 3 obligations — strongly favour obtaining all-party consent for medical recordings regardless of jurisdiction.

What "All-Party Consent" Means in Practice

In the six jurisdictions requiring all-party consent, every person whose voice is captured by the AI scribe must agree to the recording before it begins. This is not limited to the patient. If a family member, carer, interpreter, or other third party is present in the consultation room — or on a telehealth call — their consent is also required. Failing to obtain consent from a third party can constitute a criminal offence under the relevant surveillance legislation.

What Consent Must Cover

Consent should explicitly address three elements: (a) the making of the audio recording, (b) the communication of that recording to the AI scribe provider for processing, and (c) the use of the clinical notes generated from the recording. A vague "do you consent to being recorded?" is insufficient if it does not disclose the purpose and the recipient.

Practical Implementation

The most defensible approach is to obtain written consent on patient intake forms and verbal consent at the start of each recorded consultation. Document both in the patient record. This dual-consent model protects against claims that written consent was signed without understanding, and ensures consent is current and specific to the encounter.

Psychiatric consultations present heightened sensitivity, as disclosures are often deeply personal and third parties (carers, family members) are frequently involved. Our guide to AI scribes in psychiatry addresses these dynamics in detail.

TGA Regulation — When an AI Scribe Becomes a Medical Device

The Therapeutic Goods Act 1989 (Cth) defines a medical device under section 41BD. Whether an AI scribe falls within this definition depends entirely on its intended purpose as described by the manufacturer.

The TGA's Bright Line

The TGA has drawn a clear distinction:

• Not a medical device: AI scribes that only transcribe and translate clinical conversations into written records — without analysing or interpreting the content — are documentation tools, not medical devices.

• Is a medical device: AI scribes that analyse or interpret conversations to generate a diagnosis, differential diagnosis, treatment recommendation, or clinical decision support output not explicitly stated by the clinician are medical devices. These must be listed on the Australian Register of Therapeutic Goods (ARTG) before being lawfully supplied in Australia.

Why This Matters to Physicians

If you use an AI scribe that is classified as a medical device but is not listed on the ARTG, the supplier may be acting illegally under Commonwealth law. More importantly for clinicians, using an unregistered medical device could trigger professional conduct implications through AHPRA, particularly if a patient suffers harm as a result of an AI-generated recommendation that was not clinician-verified.

Practical Checklist Before Adopting an AI Scribe

• Confirm the product's intended purpose as described in the manufacturer's documentation and marketing materials.

• Determine whether the tool generates clinical recommendations, diagnostic suggestions, or treatment plans beyond what the clinician explicitly dictates.

• If the tool does generate such outputs, verify that it is listed on the ARTG by searching the TGA's public database.

• If the tool is transcription-only, confirm this in writing with the vendor and retain the confirmation for your compliance records.

Try Scribing.io Free

AHPRA, Professional Obligations, and Clinical Responsibility

Regardless of what the AI scribe does or how it is classified, AHPRA's position is straightforward: the treating physician is responsible for the clinical record. Using an AI tool does not transfer, dilute, or delegate that responsibility.

Good Medical Practice and Record-Keeping Standards

The Medical Board of Australia's Good Medical Practice: A Code of Conduct for Doctors in Australia requires physicians to maintain clear, accurate, and contemporaneous clinical records. If an AI scribe generates a note that contains an error — a misheard medication name, an incorrect dosage, a fabricated clinical detail — and the physician signs off on that note without reviewing it, the physician bears the professional and medicolegal consequences.

Delegation vs. Automation

AHPRA distinguishes between delegating a task to another health professional (who has their own registration and accountability) and automating a task using software (where the software has no registration, no liability, and no professional obligations). When you use an AI scribe, you are automating documentation — you are not delegating it. The output requires the same scrutiny you would apply to notes drafted by an unregistered assistant.

Notification Obligations

If an AI scribe systematically generates inaccurate records and a clinician fails to identify and correct the errors, this could constitute a pattern of substandard clinical practice that triggers AHPRA's mandatory notification provisions. Clinicians should establish a review workflow that includes reading every AI-generated note before it is finalised in the patient record.

Informed Consent Best Practices for Australian Clinicians

Informed consent for AI scribe use in Australia must satisfy both the Privacy Act's requirements for collection of sensitive information and the applicable state or territory surveillance law. Here is a practical framework that covers both.

Step 1: Written Disclosure at Intake

Add a clear, plain-language disclosure to your patient intake form explaining that: an AI-powered documentation tool will record and transcribe the consultation; the recording will be processed by a named third-party provider; the physician will review and finalise all clinical notes; and the patient may opt out at any time without affecting their care.

Step 2: Verbal Confirmation at Each Encounter

At the start of each consultation, verbally confirm that the AI scribe is active and that the patient consents. This is not a formality — it ensures consent is current, specific, and freely given. Record the verbal consent in the clinical notes.

Step 3: Third-Party Consent

If anyone other than the patient and physician is present — a carer, family member, interpreter, medical student, or allied health professional — obtain their consent to the recording separately. This applies in the consultation room and on telehealth calls. A single patient consent form does not cover third parties.

Step 4: Opt-Out Workflow

Ensure your practice has a clear, frictionless process for patients who decline to be recorded. This means the AI scribe must be capable of being paused or disabled mid-session without disrupting clinical workflow. Document the patient's refusal and proceed with manual note-taking or traditional dictation.

Step 5: Retention and Deletion

Inform patients how long audio recordings are retained, whether recordings are deleted after transcription, and how they can request access to or deletion of their data. These disclosures satisfy APP 1 (open and transparent management) and APP 12 (access to personal information).

Telehealth and Cross-Border Complications

Telehealth has made cross-border consultations routine in Australia — a GP in Queensland consulting a patient in Victoria, a psychiatrist in the ACT treating a patient in New South Wales. This creates a jurisdictional question that surveillance legislation does not neatly resolve: which state's recording laws apply?

The Conservative Approach

Legal commentators consistently advise that clinicians should comply with the more restrictive jurisdiction involved in any cross-border consultation. Since the majority of Australian states and territories require all-party consent, this means that in practice, all-party consent should be obtained for every telehealth consultation involving an AI scribe, regardless of where the clinician or patient is located.

Telehealth Platform Integration

When an AI scribe operates within a telehealth platform, the physician must ensure the patient is informed before the recording begins — not after the call connects. Ideally, the telehealth platform should display a notification or consent prompt to the patient prior to the consultation starting. If the platform does not offer this functionality, the physician must address consent verbally at the outset.

Medicare and PBS Compliance

The use of an AI scribe does not currently affect Medicare Benefits Schedule (MBS) item eligibility for telehealth consultations. However, the clinical notes generated by the scribe must still meet the documentation requirements for the item billed. AI-generated notes that are generic, incomplete, or inaccurate could expose the practice to Medicare compliance audits if they do not substantiate the claimed service.

For clinicians integrating AI scribes with their practice management systems, our guides to AI scribes for Epic and AI scribes for Athenahealth cover integration-specific compliance considerations.

Choosing a Compliant AI Scribe Vendor

The legal obligations described in this article fall on the physician, but a well-designed vendor makes compliance substantially easier — and a poorly designed one makes it nearly impossible. Here is what to evaluate.

Data Residency and Sovereignty

Confirm whether patient data is processed and stored within Australia. If the vendor uses offshore infrastructure, verify which countries are involved and whether the vendor's contractual terms provide APP-equivalent protections as required under APP 8. Ask for written confirmation, not marketing claims.

Encryption and Access Controls

Look for end-to-end encryption of audio recordings in transit and at rest, role-based access controls, and multi-factor authentication. Ask whether the vendor's employees can access raw audio or transcripts, and under what conditions.

Data Processing Agreements

Request the vendor's data processing agreement (or equivalent). It should specify: the categories of personal information processed, the purposes of processing, sub-processor disclosures, breach notification timelines, and data deletion commitments.

TGA Classification Transparency

A trustworthy vendor will clearly state whether its product is classified as a medical device and, if so, provide its ARTG listing number. If the vendor claims its product is not a medical device, that claim should be documented and consistent with the product's actual functionality.

Audit and Compliance Documentation

Ask whether the vendor has undergone independent security audits (e.g., SOC 2 Type II, ISO 27001) and whether audit reports are available to customers. A vendor that cannot produce evidence of independent review should be treated with caution.

Scribing.io provides detailed documentation of its security and compliance features, including data handling practices and integration capabilities, so Australian clinicians can make informed adoption decisions.

Get Started Today

AI medical scribes are legal in Australia — but legality requires active compliance, not passive assumption. Understanding your obligations under the Privacy Act, your state's surveillance legislation, and the TGA's medical device framework is the foundation. Choosing a vendor built for clinical compliance is the next step. Scribing.io gives Australian physicians ambient AI documentation with the transparency, security, and consent workflows that this regulatory landscape demands.

Start Your Free Trial — No Credit Card Required